MedTrace Logo

Efficacy of Extracorporeal Shockwave Therapy on Ultrasonographic Changes in de Quervain Tenosynovitis

NCT05782114 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-03-23

No results posted yet for this study

Summary

The current study will be conducted to explore the efficacy of ESWT on ultrasonographic changes, pain intensity level, upper limb function and hand grip strength in patients with de Quervain tenosynovitis.

Conditions

  • De Quervain Disease

Interventions

OTHER

Extracorporeal Shockwave therapy

The shockwave will be applied for the experimental group (Group A). The patients will be positioned on a chair, and the hand with the disorder will be placed on a surface with the radio ulnar joint will be in mid position and the thumb will be directed up. will be 1000 impulses with 2 bar pressure at a frequency of 15 Hz on the radial head and focused on the tissue surrounding the maximal pain point.

OTHER

Traditional physical therapy program

1. Instruction to wear Thumb Spica splint: The Thumb Spica splint will be used for 4 weeks for both groups of patients. 2. Ultrasound Therapy: Therapeutic Ultrasound parameters will be mode: continuous, duration: 5 minutes, intensity: 1.2watt/cm2 and frequency: 1MHZ. 3. Stretching exercise: 1\. Self-stretch of the thenar eminence: 2. Opposition stretches: 3. Wrist stretch: 4\) Strengthening exercise: 1. Resisted exercise for thumb extension: 2. Resisted exercise for thumb abduction: 3. Resisted exercise for thumb opposition: 4. Wrist radial deviation strengthening: 5. Grip strengthening: 6. Finger spring:

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Fatma S Amen · Profeesor of Basic Science / Faculty of Physical therapy/ Cairo university

  • Nabil M Ismail · Assistant Prof. of Basic Science/ Faculty of Physical therapy/ Cairo university

  • Doaa A Elimy · Lecturer of Basic Science /Faculty of Physical therapy/ Cairo university

  • Ahmed S Abd El Basset · Lecturer of Radiology / Faculty of Medicine/ Beni Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-04-30
Completion
2024-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05782114 on ClinicalTrials.gov